Global Artificial Intelligence (AI) In Drug Discovery Market Report 2023: Forecast Market Size, Growth Rate And Key Drivers

The global artificial intelligence (AI) in drug discovery market size will grow from $1.04 billion in 2022 to $1.38 billion in 2023 at a compound annual growth rate (CAGR) of 31.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global artificial intelligence (ai) in drug discovery market size is expected to grow to $3.74 billion in 2027 at a CAGR of 28.4%.

Global Artificial Intelligence (AI) In Drug Discovery Market Key Driver

The rise in demand for a reduction in the overall time taken for the drug discovery process is a key driver propelling the growth of the artificial intelligence (AI) in drug discovery market. Traditionally, it takes three to five years for animal models to identify and optimize molecules before they are evaluated in humans whereas start-ups based on AI have been identifying and designing new drugs in a matter of few days or months.

Get a Sample of the global artificial intelligence (AI) in drug discovery market report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=3411&type=smp

Global Artificial Intelligence (AI) In Drug Discovery Market Segments

The global artificial intelligence (AI) in drug discovery market is segmented:
• By Technology: Deep Learning, Machine Learning
• By Drug Type: Small Molecule, Large Molecules
• By Therapeutic Type: Metabolic Disease, Cardiovascular Disease, Oncology, Neurodegenerative Diseases, Other Therapeutics
• By End-Users: Pharmaceutical Companies, Biopharmaceutical Companies, Academic And Research Institutes, Other End-Users
• By Geography: The regions covered in the artificial intelligence (AI) in drug discovery global market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. Among these regions, North America accounts for the largest share in the global artificial intelligence (AI) in drug discovery market.

Major Artificial Intelligence (AI) In Drug Discovery Industry Players

IBM Corporation, Microsoft, Atomwise Inc., Deep Genomics, Cloud Pharmaceuticals, Insilico Medicine, Benevolent.

Get the full global artificial intelligence (AI) in drug discovery industry report here -
https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-drug-discovery-global-market-report

Artificial Intelligence (AI) In Drug Discovery Market Overview

Artificial intelligence (AI) is a simulation of the human intelligence in machines that are programmed to think and behave like humans. AI helps to complete the job quickly and with relatively few errors.

Artificial Intelligence (AI) In Drug Discovery Global Market Report 2023 provides data on the global artificial intelligence (AI) in drug discovery market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The artificial intelligence (AI) in drug discovery market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.